Spectral Med Inc (EDT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Spectral Med Inc (EDT) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-2.67 Million ≈ $-1.93 Million USD) by net assets (CA$-68.66 Million ≈ $-49.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Spectral Med Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Spectral Med Inc - Cash Flow Conversion Efficiency Trend (1992–2024)

This chart illustrates how Spectral Med Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Spectral Med Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spectral Med Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Seaport Entertainment Group Inc.
NYSE MKT:SEG
-0.024x
Vista Gold Corporation
NYSE MKT:VGZ
-0.036x
Ananti Inc
KQ:025980
-0.014x
Taiwan Taxi Co Ltd
TWO:2640
0.066x
Archimedes Tech SPAC Partners II Co. Unit
NASDAQ:ATIIU
0.000x
HLE Glascoat Limited
NSE:HLEGLAS
0.121x
Darwin Precisions Corp
TW:6120
0.016x
Samchully
KO:004690
0.028x

Annual Cash Flow Conversion Efficiency for Spectral Med Inc (1992–2024)

The table below shows the annual cash flow conversion efficiency of Spectral Med Inc from 1992 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Spectral Med Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$-27.55 Million
≈ $-19.93 Million
CA$-8.82 Million
≈ $-6.38 Million
0.320x -50.58%
2023-12-31 CA$-16.55 Million
≈ $-11.97 Million
CA$-10.72 Million
≈ $-7.76 Million
0.648x -83.29%
2022-12-31 CA$-2.55 Million
≈ $-1.85 Million
CA$-9.90 Million
≈ $-7.16 Million
3.876x +281.90%
2021-12-31 CA$4.08 Million
≈ $2.95 Million
CA$-8.70 Million
≈ $-6.29 Million
-2.131x -540.02%
2020-12-31 CA$-669.00K
≈ $-483.94K
CA$-324.00K
≈ $-234.38K
0.484x +139.98%
2019-12-31 CA$2.26 Million
≈ $1.63 Million
CA$-2.74 Million
≈ $-1.98 Million
-1.212x -224.12%
2018-12-31 CA$6.37 Million
≈ $4.61 Million
CA$-2.38 Million
≈ $-1.72 Million
-0.374x +70.28%
2017-12-31 CA$2.86 Million
≈ $2.07 Million
CA$-3.60 Million
≈ $-2.60 Million
-1.258x +34.17%
2016-12-31 CA$5.82 Million
≈ $4.21 Million
CA$-11.12 Million
≈ $-8.05 Million
-1.911x -13.63%
2015-12-31 CA$5.43 Million
≈ $3.93 Million
CA$-9.14 Million
≈ $-6.61 Million
-1.682x -48.20%
2014-12-31 CA$8.82 Million
≈ $6.38 Million
CA$-10.01 Million
≈ $-7.24 Million
-1.135x +29.68%
2013-12-31 CA$5.70 Million
≈ $4.12 Million
CA$-9.19 Million
≈ $-6.65 Million
-1.614x -120.87%
2012-12-31 CA$10.57 Million
≈ $7.65 Million
CA$-7.72 Million
≈ $-5.59 Million
-0.731x -120.57%
2011-12-31 CA$18.94 Million
≈ $13.70 Million
CA$-6.27 Million
≈ $-4.54 Million
-0.331x -16.50%
2010-12-31 CA$15.75 Million
≈ $11.39 Million
CA$-4.48 Million
≈ $-3.24 Million
-0.284x +64.97%
2009-12-31 CA$1.36 Million
≈ $987.42K
CA$-1.11 Million
≈ $-801.51K
-0.812x -528.74%
2008-12-31 CA$4.05 Million
≈ $2.93 Million
CA$-523.00K
≈ $-378.33K
-0.129x +4.00%
2007-12-31 CA$5.44 Million
≈ $3.94 Million
CA$-732.00K
≈ $-529.52K
-0.134x +26.00%
2006-12-31 CA$6.99 Million
≈ $5.06 Million
CA$-1.27 Million
≈ $-918.70K
-0.182x +96.81%
2005-12-31 CA$738.00K
≈ $533.86K
CA$-4.21 Million
≈ $-3.04 Million
-5.703x -500.54%
2004-12-31 CA$5.33 Million
≈ $3.85 Million
CA$-5.06 Million
≈ $-3.66 Million
-0.950x -71.08%
2003-12-31 CA$9.03 Million
≈ $6.53 Million
CA$-5.01 Million
≈ $-3.63 Million
-0.555x +48.99%
2002-12-31 CA$3.84 Million
≈ $2.78 Million
CA$-4.18 Million
≈ $-3.02 Million
-1.088x -1548.33%
2001-12-31 CA$8.19 Million
≈ $5.92 Million
CA$615.00K
≈ $444.88K
0.075x +111.47%
2000-12-31 CA$5.81 Million
≈ $4.20 Million
CA$-3.80 Million
≈ $-2.75 Million
-0.655x -35.38%
1999-12-31 CA$9.30 Million
≈ $6.73 Million
CA$-4.50 Million
≈ $-3.26 Million
-0.484x +13.98%
1998-12-31 CA$16.00 Million
≈ $11.57 Million
CA$-9.00 Million
≈ $-6.51 Million
-0.563x -47.94%
1997-12-31 CA$26.30 Million
≈ $19.03 Million
CA$-10.00 Million
≈ $-7.23 Million
-0.380x -36.39%
1996-12-31 CA$39.10 Million
≈ $28.28 Million
CA$-10.90 Million
≈ $-7.88 Million
-0.279x +36.15%
1995-12-31 CA$28.40 Million
≈ $20.54 Million
CA$-12.40 Million
≈ $-8.97 Million
-0.437x -128.79%
1994-12-31 CA$39.30 Million
≈ $28.43 Million
CA$-7.50 Million
≈ $-5.43 Million
-0.191x +5.18%
1993-12-31 CA$15.90 Million
≈ $11.50 Million
CA$-3.20 Million
≈ $-2.31 Million
-0.201x +66.75%
1992-12-31 CA$3.80 Million
≈ $2.75 Million
CA$-2.30 Million
≈ $-1.66 Million
-0.605x --

About Spectral Med Inc

TO:EDT Canada Diagnostics & Research
Market Cap
$284.46 Million
CA$393.23 Million CAD
Market Cap Rank
#15190 Global
#456 in Canada
Share Price
CA$1.36
Change (1 day)
-1.45%
52-Week Range
CA$0.79 - CA$1.75
All Time High
CA$1.89
About

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more